Formulation of Monoclonal Antibody Therapies: From Lab to Market

Formulation of Monoclonal Antibody Therapies: From Lab to Market

Elkordy, Amal Ali

161,20 €(IVA inc.)

Formulation of Monoclonal Antibody Therapies: From Lab to Market covers a wide range of topics about therapeutic monoclonal antibodies (mAbs) with a focus on formulation aspects. Therapeutic monoclonal antibodies are used for treatment of chronic diseases. It brings together a comprehensive knowledge in one accessible volume. Starting with foundational information on monoclonal antibodies, the book then discusses the importance of biopharmaceutical products, monoclonal antibodies and biosimilars in treatment of chronic diseases, pharmaceutical aspects of mAbs, and how it can be administered. The industrial point of view and the clinical application of mAbs including in oncology, general medicine, rheumatology, hematology, dermatology, gastrointestinal tract, metabolic diseases and dentistry. Formulation of Monoclonal Antibody Therapies: From Lab to Market is essential reading for researchers in biotechnology and biopharmaceutical fields, academics and pharmaceutical industrial scientists, and university students in pharmaceutical and biopharmaceutical sciences. Covers details of recent advances in using mAbsExamines how to overcome the challenges for formulations of therapeutic mAbsIncludes liposomal forms of mAbs INDICE: 1. Introduction about antibodies2. Biosimilars3. Pharmaceutical aspects of mAbs4. Route of mAbs administration5. Industrial aspects of mAbs6. Application and marketed products of mAbs

  • ISBN: 978-0-12-823365-8
  • Editorial: Academic Press
  • Encuadernacion: Rústica
  • Páginas: 245
  • Fecha Publicación: 01/10/2021
  • Nº Volúmenes: 1
  • Idioma: Inglés